ASX:ANN - Ansell Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$23.25 +0.33 (+1.44 %) (As of 11/16/2018 06:42 AM ET)Previous CloseA$22.92Today's RangeA$22.97 - A$23.4952-Week RangeA$20.30 - A$26.46Volume594,371 shsAverage Volume739,509 shsMarket CapitalizationN/AP/E Ratio7.00Dividend Yield2.88%BetaN/A ProfileDiscussionChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, Caribbean, and North America. It operates through two segments, Healthcare and Industrial. The Healthcare segment offers a range of surgical and examination gloves covering various applications; and healthcare safety devices and active infection protection products for healthcare patients. This segment's products include medical exam gloves, general disposable gloves, surgical gloves, event protection and sharps safety products, O.R. turnover solutions, patient positioners, staff and patient ergonomics, silver barrier dressings, outer dressings, medical specialty gloves, safety essentials, and fluid and trip management products, as well as burn and wound care products. It also distributes single use gloves used in industrial applications, including chemical, food services, life sciences, electronics, and automotive aftermarket. This segment offers its products under the Microflex, SANDEL, MICROTOUCH, GAMMEX, ENCORE, ANSELL MEDICAL, MEDI-GRIP, TouchNTuff, and Marigold brands for acute care hospitals, emergency services, alternate care, and dentistry and veterinary clinics. The Industrial segment provides hand, foot, and body protection solutions for industrial worker environments and specialty applications, including the automotive, chemical, food processing, life sciences, machinery and equipment, metal fabrication, mining, and oil and gas industries. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1888 and is based in Richmond, Australia. Receive ANN News and Ratings via Email Sign-up to receive the latest news and ratings for ANN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolASX:ANN Previous Symbol CUSIPN/A Webwww.ansell.comen.aspx Phone+61-3-92707270 Debt Debt-to-Equity Ratio35.61 Current Ratio3.85 Quick Ratio2.62 Price-To-Earnings Trailing P/E Ratio7.00 Forward P/E Ratio20.99 P/E GrowthN/A Sales & Book Value Annual Sales$1.49 billion Price / SalesN/A Cash FlowA$4.15 per share Price / Cash5.60 Book ValueA$10.79 per share Price / Book2.16 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees12,482 Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Ansell (ASX:ANN) Frequently Asked Questions What is Ansell's stock symbol? Ansell trades on the ASX under the ticker symbol "ANN." Has Ansell been receiving favorable news coverage? Media coverage about ANN stock has trended somewhat positive recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ansell earned a daily sentiment score of 1.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Ansell's key competitors? Some companies that are related to Ansell include Advanced Medical Solutions (AMS), Akers Biosciences (AKR), Bovie Medical (BVX), Bovie Medical (BVX), Clover (CLV), CONVATEC Grp PL/ADR (CNVVY), CRH Medical (CRHM), CRH Medical (CRH), Daxor (DXR), Enerplus (ERF), Essilor International Cmgn Gnl D Optq (EI), Gerresheimer (GXI), InfuSystem (INFU), Iris BioTechnologies (IRSB) and IsoRay (ISR). Who are Ansell's key executives? Ansell's management team includes the folowing people: Mr. Magnus R. Nicolin, MD, CEO & Exec. Director (Age 61)Mr. Neil I. Salmon BA, ACMA, Chief Financial Officer (Age 49)Mr. Steve Genzer BSc, MBA, Pres of IGBUMr. Joeseph Kubicek BA, MBA, Pres of HGBUMr. Darryl Nazareth BS, MS, MBA, Sr. VP of Operations and R&D What is Ansell's stock price today? One share of ANN stock can currently be purchased for approximately A$23.25. What is Ansell's official website? The official website for Ansell is http://www.ansell.com/en.aspx. How can I contact Ansell? Ansell's mailing address is L 3 678 Victoria St, RICHMOND, VIC 3121, Australia. The company can be reached via phone at +61-3-92707270. MarketBeat Community Rating for Ansell (ASX ANN)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 108 (Vote Outperform)Underperform Votes: 167 (Vote Underperform)Total Votes: 275MarketBeat's community ratings are surveys of what our community members think about Ansell and other stocks. Vote "Outperform" if you believe ANN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/16/2018 by MarketBeat.com StaffFeatured Article: Why do companies engage in swaps?